Choose your outcomes: From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey.
暂无分享,去创建一个
M. Mantero | G. Canonica | F. Blasi | F. Braido | I. Baiardini | G. Molinengo | S. Garuti | Marta Ferrari
[1] N. Inui,et al. Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease , 2015, International journal of chronic obstructive pulmonary disease.
[2] K. Jahnz-Różyk,et al. Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD – real-life experience from an observational study , 2015, International journal of chronic obstructive pulmonary disease.
[3] S. Minami,et al. Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease , 2015, International journal of chronic obstructive pulmonary disease.
[4] N. Inui,et al. Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease. , 2015, Pulmonary pharmacology & therapeutics.
[5] Jennifer G. Dy,et al. Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene. , 2014, Respiratory medicine.
[6] P. Zarogoulidis,et al. COPD Assessment Test: A Simple Tool to Evaluate Disease Severity and Response to Treatment , 2014, COPD.
[7] N. Chavannes,et al. Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study , 2014, PloS one.
[8] S. Kon,et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. , 2014, The Lancet. Respiratory medicine.
[9] Stephanie A. Santorico,et al. Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema , 2014, Thorax.
[10] H. Chrystyn,et al. Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD. , 2014, Respiratory medicine.
[11] M. Cazzola,et al. Long-acting bronchodilators improve health related quality of life in patients with COPD. , 2013, Respiratory medicine.
[12] F. Falcone,et al. Doctor-patient relationship: a resource to improve respiratory diseases management. , 2012, European journal of internal medicine.
[13] Edwin K Silverman,et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.
[14] P. Jones,et al. Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.
[15] Matteo Bonini,et al. Why do doctors and patients not follow guidelines? , 2009, Current opinion in allergy and clinical immunology.
[16] M. Decramer,et al. Bronchodilator responsiveness in patients with COPD , 2008, European Respiratory Journal.
[17] W. MacNee,et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.
[18] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[19] T. Mills,et al. Measuring Health: A Guide to Rating Scales and Questionnaires , 2006 .
[20] S. Ventegodt,,et al. Measurement of Quality of Life II. From the Philosophy of Life to Science , 2003, TheScientificWorldJournal.
[21] P. Velleman,et al. Nominal, Ordinal, Interval, and Ratio Typologies are Misleading , 1993 .
[22] J. Hallas,et al. Low Use and Adherence to Maintenance Medication in Chronic Obstructive Pulmonary Disease in the General Population , 2014, Journal of General Internal Medicine.
[23] O. Skjønsberg,et al. How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? , 2005, Respiratory medicine.